Genovese Burford & Brothers Wealth & Retirement Plan Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,200	Closed	-$6K	–	408
2018 Q2	$6K	Hold	3,200	–	–	﹤0.01%	350
2018 Q1	$6K	Hold	3,200	–	–	﹤0.01%	359
2017 Q4	$4K	Hold	3,200	–	–	0.01%	219
2017 Q3	$3K	Hold	3,200	–	–	﹤0.01%	369
2017 Q2	$4K	Hold	3,200	–	–	﹤0.01%	334
2017 Q1	$7K	Hold	3,200	–	–	﹤0.01%	333
2016 Q4	$7K	Hold	3,200	–	–	﹤0.01%	363
2016 Q3	$5K	Buy	3,200 +100	+3%	+$122	﹤0.01%	348
2016 Q2	$2K	Hold	3,100	–	–	﹤0.01%	377
2016 Q1	$2K	Buy	3,100 +1,100	+55%	+$1.11K	﹤0.01%	356
2015 Q4	$2K	Buy	+2,000	New	+$4.28K	﹤0.01%	350

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's MBII Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2018, closing a stake of 3,200 shares — an estimated $6K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in MBII in Q4 2015 and held it in 11 quarters. The position peaked at $7K in Q1 2017. 45 funds tracked by Wall St. Rank hold MBII as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 3,200 Marrone Bio Innovations, Inc. shares in Q3 2018, an estimated $6K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2015 and held it in 11 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Marrone Bio Innovations, Inc. position peaked at $7K in Q1 2017.
45 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.